SCHEMBL13806501

SCHEMBL13806501

CN(c1ncccc1CNc1nc(Nc2cccc(NS(C)(=O)=O)c2)ncc1C(F)(F)F)S(C)(=O)=O

nearest known ligand 0.81

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 0.81
▸ PTK2B Q14289 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628477 0.90 PTK2 (1.00) PTK2PTK2B
SCHEMBL29853506 0.90 PTK2 (1.00) PTK2PTK2B
SCHEMBL1628356 0.90 PTK2 (1.00) PTK2PTK2B
SCHEMBL1627220 0.90 PTK2 (0.86) PTK2PTK2B
SCHEMBL1626371 0.89 PTK2 (0.78) PTK2PTK2B
SCHEMBL1626469 0.89 PTK2 (1.00) PTK2PTK2B
SCHEMBL29853458 0.89 PTK2 (1.00) PTK2PTK2B
SCHEMBL1626994 0.89 PTK2 (1.00) PTK2PTK2B
SCHEMBL1627786 0.89 PTK2 (1.00) PTK2PTK2B
SCHEMBL12998430 0.89 PTK2 (0.79) PTK2PTK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461147-B2 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-11 — — US disclosed
WO-2009071535-A1 DIAMINOPYRIDINES FOR THE TREATMENT OF DISEASES WHICH ARE CHARACTERISED BY EXCESSIVE OR ANOMAL CELL PROLIFERATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-06-11 — — WO disclosed
Send feedback